{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:26:36Z","timestamp":1757586396948},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4de"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00132-008-1397-z","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T17:00:04Z","timestamp":1244653204000},"page":"501-510","source":"Crossref","is-referenced-by-count":9,"title":["Kristallarthropathien","Crystal arthropathies"],"prefix":"10.1007","volume":"38","author":[{"given":"M.","family":"Fuerst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Haybaeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"R\u00fcther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,10]]},"reference":[{"key":"1397_CR1","unstructured":"Ryan LM, McCarthy DJ (1997) Calcium pyrophosphate crystal deposition disease, pseudogout and articular chondrocalcinosis. In: Koopman WJ (ed) Arthritis and allied conditions, 13th edn. Wiliams\u00a0&\u00a0Wilkins, Baltimore, pp\u00a02103\u20132105"},{"key":"1397_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/joca.2002.0861","volume":"11","author":"Nalbant","year":"2003","unstructured":"Nalbant S, Martinez JA, Kitumnaypong T et al (2003) Synovial fluid features and their relations to osteoarthritis severity: New findings from sequential studies. Osteoarthritis Cartilage 11: 50\u201354","journal-title":"Osteoarthritis Cartilage"},{"key":"1397_CR3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1074\/jbc.M604732200","volume":"12","author":"Gajjeraman","year":"2007","unstructured":"Gajjeraman S, Narayanan K, Hao J et al (2007) Matrix macromolecules in hard tissues control the nucleation and hierarchical assembly of hydroxyapatite. J Biol Chem 12(282): 1193\u20131204","journal-title":"J Biol Chem"},{"key":"1397_CR4","first-page":"570","volume":"29","author":"Derfus","year":"2002","unstructured":"Derfus BA, Kurian JB, Butler JJ et al (2002) The high prevalence of pathologic calcium crystals in preoperative knees. J Rheumatol 29: 570\u2013573","journal-title":"J Rheumatol"},{"key":"1397_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/b716791a","volume":"133","author":"Yavorskyy","year":"2008","unstructured":"Yavorskyy A, Hernandez-Santana A, McCarthy G, McMahon G (2008) Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis-analytical approaches and challenges. Analyst 133: 302\u2013318","journal-title":"Analyst"},{"key":"1397_CR6","doi-asserted-by":"crossref","unstructured":"Thouverey C, Beckhoff G, Pikula S, Buchet R (2008) Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dyhydrate mineral deposition by matrx vesicles. Osteoarthritis Cartilage (Epub ahead of print)","DOI":"10.1016\/j.joca.2008.05.020"},{"key":"1397_CR7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s002239900523","volume":"63","author":"Derfus","year":"1998","unstructured":"Derfus B, Kranendonk S, Camacho N et al (1998) Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 63: 258\u2013262","journal-title":"Calcif Tissue Int"},{"key":"1397_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/03008209609029209","volume":"35","author":"Derfus","year":"1996","unstructured":"Derfus BA, Kurtin SM, Camacho NP et al (1996) Comparison of matrix vesicles derived from normal and osteoarthritic human articular cartilage. Connect Tissue Res 35: 337\u2013342","journal-title":"Connect Tissue Res"},{"key":"1397_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.joca.2003.12.004","volume":"12","author":"Johnson","year":"2004","unstructured":"Johnson K, Terkeltaub R (2004) Upregulated ank expression in osteoarthritis can promote both chondrocyte mmp-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthritis Cartilage 12: 321\u2013335","journal-title":"Osteoarthritis Cartilage"},{"key":"1397_CR10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/343053","volume":"71","author":"Williams","year":"2002","unstructured":"Williams CJ, Zhang Y, Timms A et al (2002) Autosomal dominant family calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembran protein ANKH. Am J Hum Genet 71: 985\u2013951","journal-title":"Am J Hum Genet"},{"key":"1397_CR11","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/art.10632","volume":"46","author":"Hirose","year":"2002","unstructured":"Hirose J, Lawrence MR, Masuda I (2002) Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 46: 3218\u20133229","journal-title":"Arthritis Rheum"},{"key":"1397_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s100670050034","volume":"19","author":"Kroesen","year":"2000","unstructured":"Kroesen S, Schmid W, Theiler R (2000) Induction of an accut attack of calcium pyrophosphat dihydrate arthritis by intraacticular injection of hylan G-F 20 (Synvisc). Clin Rheum 19: 147\u2013149","journal-title":"Clin Rheum"},{"key":"1397_CR13","first-page":"555","volume":"42","author":"Cheung","year":"1999","unstructured":"Cheung HS, Kurup IV, Sallis JD, Ryan LM (1999) Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate. J Biol Chem 42(3): 555\u2013560","journal-title":"J Biol Chem"},{"key":"1397_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0889-857X(21)00972-8","volume":"14","author":"Doherty","year":"1988","unstructured":"Doherty M, Diepe PA (1988) Clinical aspect of calciumpyrophosphate dihydrate deposition. Rheum Dis Clin North Am 14: 395\u2013414","journal-title":"Rheum Dis Clin North Am"},{"key":"1397_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.bor.0000218944.89365.dd","volume":"18","author":"Ellman","year":"2006","unstructured":"Ellman MH, Becker MA (2006) Crystal-inducd arthropathies: Recent investigative advances. Curr Opin Rheumatol 18: 249\u2013255","journal-title":"Curr Opin Rheumatol"},{"key":"1397_CR16","first-page":"1582","volume":"31","author":"Wallace","year":"2004","unstructured":"Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10 years among old adults in a managed care population. J Rheumatol 31: 1582\u20131587","journal-title":"J Rheumatol"},{"key":"1397_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB (2005) Gout epidemiology: Results from the UK General Practise Research Database, 1990\u20131999. Ann Rheum Dis 64: 267\u2013272","journal-title":"Ann Rheum Dis"},{"key":"1397_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.0000254480.64564.b6","volume":"49","author":"Krishnan","year":"2007","unstructured":"Krishnan E, Kwoh CK, Schumacher HR, Kuller L (2007) Hyperuricemia and incidence of hypertension in men without metabolic syndrome. Hypertension 49: 298\u2013303","journal-title":"Hypertension"},{"key":"1397_CR19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"Choi","year":"2007","unstructured":"Choi HK, Ford ES (2007) Prevalence of metabolic syndrome in individuals with hyperuricemia. Am J Med 120: 442\u2013447","journal-title":"Am J Med"},{"key":"1397_CR20","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","volume":"52","author":"Liu-Bryan","year":"2005","unstructured":"Liu-Bryan R, Scott P, Sydlaske A et al (2005) Innate immunity conferred by Toll-like receptor 2 and 4 myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthrits Rheum 52: 2936\u20132946","journal-title":"Arthrits Rheum"},{"key":"1397_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A et al (2006) Gout associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237\u2013241","journal-title":"Nature"},{"key":"1397_CR22","doi-asserted-by":"crossref","unstructured":"So A, Desmedt T, Revaz S, Tschopp J (n d) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9: 28","DOI":"10.1186\/ar2143"},{"key":"1397_CR23","first-page":"631","volume":"7","author":"Verbruggen","year":"1989","unstructured":"Verbruggen LA, Bourgain C, Verbeelen D (1989) Late presentation and microcrystalline arthropathy in primary hyperoxaluria. Clin Exp Rheumatol 7(6): 631\u2013633","journal-title":"Clin Exp Rheumatol"},{"key":"1397_CR24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11926-002-0074-1","volume":"4","author":"Maldonado","year":"2002","unstructured":"Maldonado I, Prasad V, Reginato AJ (2002) Oxalate crystal deposition disease. Curr Rheumatol Rep 4(3): 257\u2013264","journal-title":"Curr Rheumatol Rep"}],"container-title":["Der Orthop\u00e4de"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-008-1397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00132-008-1397-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-008-1397-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T06:58:34Z","timestamp":1633589914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00132-008-1397-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1007\/s00132-008-1397-z","relation":{},"ISSN":["0085-4530","1433-0431"],"issn-type":[{"value":"0085-4530","type":"print"},{"value":"1433-0431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}